Viewing Study NCT00719550


Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2025-12-29 @ 12:17 PM
Study NCT ID: NCT00719550
Status: COMPLETED
Last Update Posted: 2013-12-05
First Post: 2008-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module